Novartis Sales Rep California Overtime Legal News Articles & Interviews

Basel, Switzerland After winning approval for the multiple sclerosis treatment Gilenya in September, Novartis pharmaceutical sales have grown steadily, particularly as the company has increased the price of the pill, Bloomberg reports.